FindTrial
Sign In

Experimental study on reducing RIHD in breast cancer based on improved radiotherapy technology

Experimental study on reducing RIHD in breast cancer based on improved radiotherapy technology

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012551
Enrollment
Unknown
Registered
2017-09-02
Start date
2017-10-01
Completion date
Unknown
Last updated
2017-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

experimental group:radiotherapy with improved technology
control group:normal radiotherapy

Sponsors

the First Affiliated Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
29 Years to 69 Years

Inclusion criteria

Inclusion criteria: patients in whom adjuvant RT following breast-conserving surgery for breast carcinoma of the left side was indicated.

Exclusion criteria

Exclusion criteria: patients who has breast carcinoma of the right side.

Design outcomes

Primary

MeasureTime frame
cytokines;troponin;myocardial enzymogram;echocardiographic;Myocardial perfusion imaging;cardiac magnetic resonance imaging;—

Countries

China

Contacts

Public ContactLu Zhongjie

the First Affiliated Hospital, College of Medicine, Zhejiang University

luzhongjie@zju.edu.cn+86 13588033911

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 25, 2026